OpenLegislation

Division 2.3.1

United Kingdom

Original text. Later amendments are not shown.

Avermectins

Phramacologically active substance(s)Marker residueAnimal speciesMRLsTarget tissuesOther provisions
AbamectinAvermectin B1aBovine10 μg/kgFat
20 μg/kgLiver
DoramectinDoramectinBovine10 μg/kgMuscleNot for use in bovine from which milk is produced for human consumption
150 μg/kgFat
100 μg/kgLiver
30 μg/kgKidney
Porcine, ovine20 μg/kgMuscleNot for use in ovine from which milk is produced for human consumption
100 μg/kgFat
50 μg/kgLiver
30 μg/kgKidney
EprinomectinEprinomectin B1aBovine30 μg/kgMuscle
30 μg/kgFat
600 μg/kgLiver
100 μg/kgKidney
30 μg/kgMilk
Ivermectin22, 23-Dihydro-avermectin B1aBovine40 μg/kgFat
100 μg/kgLiver
Porcine, ovine, equidae20 μg/kgFat
15 μg/kgLiver
Deer, including reindeer20 μg/kgMuscle
100 μg/kgFat
50 μg/kgLiver
20 μg/kgKidney
MoxidectinMoxidectinBovine, ovine50 μg/kgMuscle
500 μg/kgFat
100 μg/kgLiver
50 μg/kgKidney